The Senate Health, Education, Labor & Pensions Committee today held the third in a series of bipartisan hearings on how to make prescription drugs more affordable, which focused on recent recommendations from a National Academies of Sciences, Engineering and Medicine report. In a statement submitted to the committee in June, AHA urged Congress and the administration to address the rising cost of drugs, and offered specific recommendations to increase competition, innovation and transparency, promote payment for value, improve access and align incentives. In her opening remarks at today’s hearing, Committee Ranking Member Patty Murray (D-WA) criticized the administration for reducing Medicare payments for hospital outpatient drugs under the 340B drug savings program by nearly 30% effective Jan. 1. “Not only will this do absolutely nothing to combat high drug prices, it will result in less funding for safety net providers to provide critical services to low-income and vulnerable patients,” she said. Last month, AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals filed a federal lawsuit to prevent the payment cut.

Related News Articles

Headline
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Headline
Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive…
Headline
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2017 data.
Headline
The House Energy and Commerce Health Subcommittee today held a hearing to discuss seven bills aimed at increasing competition in the prescription drug market…
Headline
The Senate Special Committee on Aging today concluded a two-part hearing on the impact of rising prescription drug costs on seniors and potential policy…
Headline
Eight in 10 U.S. adults say prescription drug costs are “unreasonable,” and one in four say their prescription medicines are difficult to afford, according to…